文献速递食管与纵隔外科

早期无肌无力胸腺瘤:胸腺瘤切除联合全胸腺切除优于单纯胸腺瘤切除

Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis: a European Society of Thoracic Surgeons Thymic Working Group Study.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

欧洲胸外科医师学会胸腺工作组基于胸腺数据库比较无肌无力(non-MG)病理I期胸腺瘤患者行胸腺瘤切除联合全胸腺切除(TT)与单纯胸腺瘤切除(ST)的短期和长期结局。共纳入498例,TT组466例(93.6%),ST组32例(6.4%)。TT组5年总生存率89%、5年无复发生存率96%,ST组分别为55%和79%;两组术后并发症率、30天死亡率和术后住院时间无差异。结论为早期无MG胸腺瘤患者行TT可获得显著更优的无复发生存,且不增加术后并发症。

要点

  • 早期无肌无力胸腺瘤行TT较ST显著改善5年无复发生存(96% vs 79%)。
  • TT组5年总生存率89%,ST组55%。
  • 两组术后并发症、30天死亡率和术后住院时间无差异。

核心结论

  • 无肌无力早期胸腺瘤患者行胸腺瘤切除联合全胸腺切除(TT)较单纯胸腺瘤切除(ST)显著改善无复发生存,且不增加术后并发症。

研究设计与样本

  • 基于欧洲胸外科医师学会胸腺数据库的回顾性比较研究,纳入498例无肌无力病理I期胸腺瘤患者,TT组466例(93.6%),ST组32例(6.4%),行倾向性评分校正比较。

主要发现

  • TT组与ST组术后并发症率、30天死亡率和术后住院时间相同。
  • TT组5年总生存率为89%,ST组为55%。
  • TT组5年无复发生存率为96%,ST组为79%。

临床怎么用

  • 对无肌无力的早期胸腺瘤患者,优先选择胸腺瘤切除联合全胸腺切除(TT)以降低复发风险。

局限性

  • ST组样本量小(32例),组间比较可能受混杂因素影响,尽管采用了倾向性评分校正。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Resection of thymic tumours including the removal of both the tumour and the thymus gland (thymothymectomy; TT) is the procedure of choice and is recommended in most relevant articles in the literature. Nevertheless, in recent years, some authors have suggested that resection of the tumour (simple thymomectomy; ST) may suffice from an oncological standpoint in patients with early-stage thymoma who do not have myasthenia gravis (MG) (non-MG). The goal of our study was to compare the short- and long-term outcomes of ST versus TT in non-MG early-stage thymomas using the European Society of Thoracic Surgeons thymic database. METHODS: A total of 498 non-MG patients with pathological stage I thymoma were included in the study. TT was performed in 466 (93.6%) of 498 patients who had surgery with curative intent; ST was done in 32 (6.4%). The completeness of resection, the rate of complications, the 30-day mortality, the overall recurrence and the freedom from recurrence were compared. We performed crude and propensity score-adjusted comparisons by surgical approach (ST vs TT). RESULTS: TT showed the same rate of postoperative complications, 30-day mortality and postoperative length of stay as ST. The 5-year overall survival rate was 89% in the TT group and 55% in the ST group. The 5-year freedom from recurrence was 96% in the TT group and 79% in the ST group. CONCLUSION: Patients with early-stage thymoma without MG who have a TT show significantly better freedom from recurrence than those who have an ST, without an increase in postoperative morbidity rate.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Guerrera F, Falcoz PE, Moser B, et al. Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis: a European Society of Thoracic Surgeons Thymic Working Group Study. Eur J Cardiothorac Surg. 2021. PMID: 34023891. doi:10.1093/ejcts/ezab224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。